Mill Creek Capital Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Mill Creek Capital Advisors, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $63.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$63.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 227,635 | $55.6M |
| AMGNAMGEN INC | 4,238 | $1.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,134 | $1.1M |
| ELVElevance Health Inc. | 3,474 | $1.0M |
| MRKMerck & Co., Inc. | 5,935 | $714K |
| SRRKScholar Rock Holding Corp | 12,664 | $623K |
| PGENPRECIGEN, INC. | 150,150 | $581K |
| LLYELI LILLY & Co | 614 | $564K |
| ABBVAbbVie Inc. | 1,821 | $396K |
| GILDGILEAD SCIENCES, INC. | 2,761 | $385K |
| CNTXContext Therapeutics Inc. | 104,631 | $274K |
| ABTABBOTT LABORATORIES | 2,336 | $240K |
| PMPhilip Morris International Inc | 1,320 | $218K |
| OPKOPKO HEALTH, INC. | 14,383 | $16K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.